2 Top Biotech Buyout Candidates

Buyout mania has definitely taken over the biopharma industry lately. With the year winding down, we've witnessed numerous transactions in the space at absolutely gobsmacking premiums. Here is a brief overview of the biggest deals over the past two months.

Best of all, this trend should endure well into the new year. Several top pharmas, after all, are currently dealing with major patent expires, novel competition entering the marketplace, as well as pressure from lawmakers to rethink their drug pricing policies.

Image source: Getty Images.

Source Fool.com